MedicinesFAQ

Pardoprunox Uses, Dosage, Side Effects and more

Pardoprunox has been used in trials studying the treatment of Early Stage Parkinson's Disease and Advanced Stage Parkinson's Disease. Pardoprunox is a partial dopamine D2 agonist and noradrenergic agonist with serotonin 5-HT1A agonist properties.

Attribute Details
Trade Name Pardoprunox
Generic Pardoprunox
Pardoprunox Other Names Pardoprunox
Type
Formula C12H15N3O2
Weight Average: 233.271
Monoisotopic: 233.116426735
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am
   

How Pardoprunox works

Pardoprunox binds to dopamine D(2), D(3), and D(4) receptors and 5-HT(1) (A) receptors and is a partial agonist at dopamine D(2) and D(3) receptors and a full agonist at serotonin 5-HT(1) (A) receptors. Pardoprunox combines high potency partial agonism at dopamine D(2) and D(3) receptors with full efficacy low potency serotonin 5-HT(1) (A) receptor agonism and is worthy of profiling in in vivo models of Parkinson's disease.

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.